Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms

Tumor marker determinations are valuable tools for the guidance of breast cancer patients during the course of disease. They are assessed on diverse analytical platforms that may be associated with differences according to the methods applied and the clinical performance. To investigate the method d...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Lars Schröder, Michael R. Mallmann, Christian M. Domroese, Natalie Wefers, Ramona Dolscheid-Pommerich, Birgit Stoffel-Wagner, Inga Trulson, Kai Vahldiek, Frank Klawonn, Stefan Holdenrieder
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Subjects:	breast cancer tumor marker method comparison CEA CA 15-3 CA 125
Online Access:	https://www.mdpi.com/2075-4418/13/19/3101